Zusammenfassung
Die multiple Sklerose (MS) ist eine der häufigsten neurologischen Erkrankungen, für deren Ursache es bislang keine einheitliche Erklärung gibt. Entscheidend für die Diagnosestellung sind die klinischen Symptome, ergänzt durch die Magnetresonanztomografie (MRT). Hauptkriterium ist die örtliche und zeitliche Dissemination von entzündlichen Manifestationen im ZNS. Eine Liquoruntersuchung zum Nachweis der entzündlichen Genese nachgewiesener multifokaler Störungen ist bei allen unklaren Fällen und bei älteren Patienten erforderlich. Zur Bestätigung und Verlaufskontrolle sind elektrophysiologische Verfahren hilfreich.
Literatur
Barkhof F, Calabresi PA, Miller DH, Reingold SC (2009) Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 5(5):256–266
Calabrese M, Filippi M, Rovaris M et al (2008) Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study. NeuroImage 42:1324–1328
Chen JT, Collins DL, Atkins HL et al (2008) Magnetisation transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 63:254–262
Costello F, Coupland S, Hodge W et al (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59(6):963–969
Di Maggio G, Santangelo R, Guerrieri S et al (2014) OCT and VEP: which is more sensitive in multiple sclerosis. MSJ. https://doi.org/10.1177/1352458514524293
Faiss JH, Köhler W (2018) MS – nursing. In: Schmidt RM, Hoffmann FA, Faiss JH, Köhler W, Zettl UK (Hrsg) Multiple Sklerose, 7. Aufl. Elsevier, München, S 415–420
Fernando KTM, Tozer DJ, Miszkiel KA et al (2005) Magnitization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 128:2911–2925
Filippi M, Rocca MA, Ciccarelli O et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 15:292–303
Frohman EM, Costello F, Zivadinov R et al (2006) Optical coherence tomography in multiple sclerosis. Lancet Neurol 5:853–863
Frohman EM, Fujimoto JG, Frohman TC et al (2008) Optical coherence tomography: a window into the mechanism of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–675
Gracien RM, Jurcoane A, Wagner M et al (2016) Multimodal quantitative MRI assessment of cortical damage in RRMS. JMRI 44:1600–1607
Hagens M, Berckel B, Barkhof F (2016) Novel MRI and PET markers of neuroinflammation in MS. Curr Opin Neurol 29:229–236
Heckl RW (1994) Multiple Sklerose: Klinik, Differenzialdiagnose, Behandlung. Thieme, Stuttgart
Kelly SB, Kinsella K, Duggan M et al (2013) A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis. Mult Scler Jul 19(8):1095–1100
Kornek B (2012) Treatment of pediatric MS. Neuropediatrics 44(06):309–313
Kurtzke JF (1983) Rating neurologic impairment in MS: an expanded disability status scale (EDSS). Neurology 89:714–721
Leocani L, Rocca MA, Comi G (2016) MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis. Curr Opin Neurol 29:243–253
McDonald W, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Petzold A, de Boer JF, Schippling S et al (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9:921–932
Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protokol. Nat Rev Neurol 10(8):447–458
Polman CH, Rudick A (2010) The MSFC: a clinically meaningful measure of disability. Neurology 74(Suppl. 3):S8–S15
Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions of the „McDonald criteria“. Ann Neurol 58(6):840–846
Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for MS: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302
Ratchford JN, Saidha S, Sotirchos ES et al (2012) Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology 80(1):47–54
Robinson I (1991) The context and consequences of communicating the diagnosis of multiple sclerosis. In: Wiethölter H, Dichgans J, Mertin J (Hrsg) Current concepts in multiple sclerosis. Elsevier, Amsterdam, S 17–22
Sailer M, Fazekas F, Gass A et al (2008) Zerebrale und spinale MRT-Untersuchung bei Patienten mit klinisch isoliertem Syndrom oder gesicherter Multipler Sklerose. Fortschr Röntgenstr 180:994–1001
Scheglmann K (1995) Multiple Sklerose: Multimodal evozierte Potenziale in der Diagnose. TW Neurol Psychiatr 9:562–573
Schippling S, Balk L, Costello F et al (2014) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler 21:163. https://doi.org/10.1177/1352458514538110 [Epub vor Druck]
Schlaeger R, Schindler C, Grize L et al (2014) Combined visual and motor evoked potentials predict MS disability after 20 years. MSJ. https://doi.org/10.1177/1352458514525867
Schneider E, Zimmermann H, Oberwahrenbrock T et al (2013) Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis. PLoS One 8(6):e66151
Solomon AS, Bourdette DN, Cross AH et al (2016) The contemporary spectrum of MS misdiagnosis. Neurology 87:1393–1399
Sombekke MH, Watties MP, Balk LJ et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis. Neurol 80(1):69–75
Thompson AJ, Banwell BI, Barkhof F et al (2018) Diagnosis of MS: 2017 revision of the McDonald criteria. Lancet Neurol 17:162–173
Tintoré M, Rovira A, Rio J et al (2008) Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 70:1079–1083
Villar LM, Garcia-Barragán N, Sádaba MC et al (2008) Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Neurol Sciences 266:34–37
Young KL, Brandt AU, Petzold A et al (2013) Loss of retinal fiber layer axons indicates white but not gray matter damage in early multiple sclerosis. Eur J Neurol 20(5):803–811
Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N (2008) Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131:288–303
Zivadinov R (2007) Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology 68(Suppl):S72–S82
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Faiss, J. (2019). Multiple Sklerose: Diagnostik. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_159-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-44768-0_159-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44768-0
Online ISBN: 978-3-662-44768-0
eBook Packages: Springer Referenz Medizin